Skip to main content
. 2021 Apr 30;12(5):428. doi: 10.1038/s41419-021-03628-5

Fig. 1. Low expression of ADAMTS9 in GC tissues was associated with the more metastatic LNs and the poorer survival outcomes of GC patients.

Fig. 1

A mRNA expression levels of ADAMTS9 in GC tissues and matched non-tumor tissues were analyzed by reverse transcriptase PCR assay. B Correlation analysis was performed between ADAMTS9 mRNA expression and metastatic LNs. C Protein expression levels of ADAMTS9 in GC tissues and matched adjacent non-tumor tissues were analyzed by IHC assay. D ADAMTS9 protein was significantly decreased in GC tissues. E Low expression level of ADAMTS9 was closely associated with more metastatic LNs in GC patients. F Keplan–Meier survival analysis was performed in 129 GC patients and stratification by pN stage.